The Sleepio After Cancer Study

NCT ID: NCT05816460

Last Updated: 2023-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

308 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-22

Study Completion Date

2024-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will recruit women over the age of 18 with a current or prior cancer diagnosis who have clinical insomnia. This study will examine the efficacy of digital cognitive behavioural therapy for insomnia (dCBT-I) compared to sleep hygiene education.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women who are eligible and provide informed consent will be enrolled into this 2-armed, parallel group open label randomised controlled trial. Participants will be randomised 1:1 to receive dCBT-I (intervention arm) or to sleep hygiene education (control arm). The primary outcome will be the mean continuous change in sleep condition indicator (SCI) score in the intervention arm compared to the control arm at 6 months. In addition to this, the proportion of women with an SCI \> 16 at 6 months will be assessed. Secondary outcomes will include fatigue, sleep related quality of life, depression, anxiety, as well as hot flush interference in those experiencing vasomotor symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

2-armed, parallel group open label randomised controlled trial. Participants will be randomised 1:1 to receive dCBT-I (intervention arm) or to sleep hygiene education (control arm).
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I)

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) will be provided on an online digital platform called Sleepio (BigHealth Ltd). Sleepio delivers fully automated CBT-I through 6 sessions, lasting an average of 20 minutes each, over the course of 6 weeks.

Group Type EXPERIMENTAL

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I)

Intervention Type OTHER

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) will be delivered through an online platform called Sleepio (BigHealth Ltd)

Sleep Hygiene Education (SHE)

The Sleep Hygiene Education (SHE) provided is based on recognised sleep hygiene advice and will consist of behavioural recommendations concerning lifestyle and environmental factors associated with sleep and insomnia. SHE will be delivered electronically.

Group Type ACTIVE_COMPARATOR

Sleep Hygiene Education (SHE)

Intervention Type OTHER

Sleep Hygiene Education (SHE) will be provided electronically

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I)

Digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) will be delivered through an online platform called Sleepio (BigHealth Ltd)

Intervention Type OTHER

Sleep Hygiene Education (SHE)

Sleep Hygiene Education (SHE) will be provided electronically

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* Aged 18 and over
* Sleep Condition Indicator (SCI) score of 16 or less
* Current or past diagnosis of cancer
* Fluent in written and spoken English
* Internet access and comfortable with its use

Exclusion Criteria

* Acute Illness
* Life expectancy less than 6 months
* Evidence of another sleep disorder
* Untreated Psychiatric Disorder
* Drug Misuse
* Currently receiving CBT for insomnia from a health professional or taking part in an online treatment programme for insomnia
* Any condition that may be exacerbated by sleep restriction therapy (Obstructive sleep apnoea, Bipolar disorder, psychosis, schizophrenia, epilepsy, current suicidal ideation, shift work, dementia, Parkinson's disease, Lewy body dementia)
* Planned Major Surgery
* Commencement or a change in sleep medication within the last 4 weeks
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Irish Cancer Society

OTHER

Sponsor Role collaborator

Big Health Ltd.

UNKNOWN

Sponsor Role collaborator

Research Electronic Data Capture (REDCap)

UNKNOWN

Sponsor Role collaborator

University College Dublin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Donal Brennan, PhD

Role: PRINCIPAL_INVESTIGATOR

University College Dublin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University College Dublin

Dublin, , Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Donal Brennan, PhD

Role: CONTACT

+353879577510

Teresa Treacy, MB, BCh, BAO

Role: CONTACT

+353861606647

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Donal Brennan, PhD

Role: primary

+353879577510

Teresa Treacy, MB, BCh, BAO

Role: backup

+353861606647

References

Explore related publications, articles, or registry entries linked to this study.

Treacy T, O'Meara Y, Galligan MC, Henry AL, Lensen SF, Higgins MJ, Hickey M, Brennan DJ. The Sleepio After Cancer (SAC) study. Digital cognitive behavioural therapy for insomnia (dCBT-I) in women cancer patients - Trial protocol of a randomised controlled trial. Contemp Clin Trials. 2024 Jan;136:107337. doi: 10.1016/j.cct.2023.107337. Epub 2023 Sep 21.

Reference Type DERIVED
PMID: 37741507 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WHI22BRE

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

WHI22BRE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Sleep in Gynecologic Cancer Survivors
NCT05044975 ACTIVE_NOT_RECRUITING NA
Mindfulness and CBT for Sleep
NCT04736056 COMPLETED NA